Home - Products - Others - Other Targets - Lauroyl-L-carnitine (chloride)

Lauroyl-L-carnitine (chloride)

CAS No. 6919-91-1

Lauroyl-L-carnitine (chloride)( —— )

Catalog No. M35020 CAS No. 6919-91-1

Lauroyl-L-carnitine (chloride) (Lauroyl-L-carnitine Hydrochloride), an acylcarnitine and surfactant, has been used to permeate porcine intestinal cells to deliver the polar fluorescent probe fluorescent yellow.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 61 In Stock
5MG 64 In Stock
10MG 102 In Stock
25MG 146 In Stock
50MG 221 In Stock
100MG 324 In Stock
500MG 779 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lauroyl-L-carnitine (chloride)
  • Note
    Research use only, not for human use.
  • Brief Description
    Lauroyl-L-carnitine (chloride) (Lauroyl-L-carnitine Hydrochloride), an acylcarnitine and surfactant, has been used to permeate porcine intestinal cells to deliver the polar fluorescent probe fluorescent yellow.
  • Description
    Lauroyl-L-carnitine chloride can be used as an absorption enhancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6919-91-1
  • Formula Weight
    379.96
  • Molecular Formula
    C19H38ClNO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (131.59 mM; Ultrasonic )
  • SMILES
    [C@H](OC(CCCCCCCCCCC)=O)(C[N+](C)(C)C)CC(O)=O.[Cl-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fu, Ling, et al. An oral pharmaceutical composition of a peptide amide compound (I, compound A). The present invention further relates to a method for preparing an oral pharmaceutical composition, and the use of the oral pharmaceutical composition in preparing a drug for treating diseases or conditions related to the κ-opioid receptor. China, WO2021185265. 2021-09-23
molnova catalog
related products
  • Shionone

    Shionone has anti-tussive and anti-inflammatory effects.

  • Rilematovir

    JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.

  • Marmin

    Marmin have anti-ulcer effects, which are ascribed primarily to the maintenance of the mucosal barrier integrity and inhibition of gastric motor activity and secondarily due to the prevention of the effects of endogenous acetylcholine and histamine.